Related Content
Search Google Scholar for:
|
Published Online December 14, 2006 Science
DOI: 10.1126/science.1133542
|
|
Research Articles
Submitted on August 7, 2006
Accepted on December 6, 2006
Histocompatible Embryonic Stem Cells by Parthenogenesis
Kitai Kim 1,
Paul Lerou 2,
Akiko Yabuuchi 1,
Claudia Lengerke 1,
Kitwa Ng 1,
Jason West 1,
Andrew Kirby 3,
Mark J. Daly 3,
George Q. Daley 4*
1 Division of Pediatric Hematology/Oncology, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.
2 Division of Pediatric Hematology/Oncology, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Division of Newborn Medicine, Brigham and Women's Hospital and Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
3 Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02115, USA.
4 Division of Pediatric Hematology/Oncology, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.
* To whom correspondence should be addressed.
George Q. Daley , E-mail: george.daley{at}childrens.harvard.edu
Genetically matched pluripotent embryonic stem cells generated via nuclear transfer (ntES cells) or parthenogenesis (pES cells) are a potential source of histocompatible cells and tissues for transplantation. Following parthenogenetic activation of murine oocytes and interruption of meiosis I or II, we have isolated and genotyped pES cells and characterized those that carry the full complement of major histocompatibility complex (MHC) antigens of the oocyte donor. Differentiated tissues from these pES cells engraft in immunocompetent MHC-matched mouse recipients, demonstrating that selected pES cells can serve as a source of histocompatible tissues for transplantation.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Correlation of expression and methylation of imprinted genes with pluripotency of parthenogenetic embryonic stem cells.
- C. Li, Z. Chen, Z. Liu, J. Huang, W. Zhang, L. Zhou, D. L. Keefe, and L. Liu (2009)
Hum. Mol. Genet.
18, 2177-2187
| Abstract »
| Full Text »
| PDF »
- Change in gene expression of mouse embryonic stem cells derived from parthenogenetic activation.
- S. P. Gong, H. Kim, E. J. Lee, S. T. Lee, S. Moon, H.-J. Lee, and J. M. Lim (2009)
Hum. Reprod.
24, 805-814
| Abstract »
| Full Text »
| PDF »
- ADP-Ribosylation Factor 1 Regulates Asymmetric Cell Division in Female Meiosis in the Mouse.
- S. Wang, J. Hu, X. Guo, J. X. Liu, and S. Gao (2009)
Biol Reprod
80, 555-562
| Abstract »
| Full Text »
| PDF »
- Understanding pluripotency--how embryonic stem cells keep their options open.
- B.V. Johnson, N. Shindo, P.D. Rathjen, J. Rathjen, and R.A. Keough (2008)
Mol. Hum. Reprod.
14, 513-520
| Abstract »
| Full Text »
| PDF »
- Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease.
- R. Sanchez-Pernaute, H. Lee, M. Patterson, C. Reske-Nielsen, T. Yoshizaki, K. C. Sonntag, L. Studer, and O. Isacson (2008)
Brain
131, 2127-2139
| Abstract »
| Full Text »
| PDF »
- Towards the Generation of Patient-Specific Pluripotent Stem Cells for Combined Gene and Cell Therapy of Hematologic Disorders.
- G. Q. Daley (2007)
Hematology
2007, 17-22
| Abstract »
| Full Text »
| PDF »
|
|